Vincent Grass
Overview
Explore the profile of Vincent Grass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
602
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko C, Cheng C, Mistretta D, Ambike S, Sacherl J, Velkov S, et al.
J Med Virol
. 2025 Jan;
97(1):e70156.
PMID: 39760326
SARS-CoV-2 infection is accompanied by elevated liver enzymes, and patients with pre-existing liver conditions experience more severe disease. While it was known that SARS-CoV-2 infects human hepatocytes, our study determines...
2.
Huang Y, Bergant V, Grass V, Emslander Q, Hamad M, Hubel P, et al.
Nat Commun
. 2024 Aug;
15(1):6778.
PMID: 39117661
Multiple omics analyzes of Vaccinia virus (VACV) infection have defined molecular characteristics of poxvirus biology. However, little is known about the monkeypox (mpox) virus (MPXV) in humans, which has a...
3.
Macht A, Huang Y, Reinert L, Grass V, Lohmer K, Aristizabal Prada E, et al.
EMBO Rep
. 2024 Jul;
25(9):3777-3788.
PMID: 39060455
RNA vaccines elicit protective immunity against SARS-CoV-2, but the use of mRNA as an antiviral immunotherapeutic is unexplored. Here, we investigate the activity of lipidoid nanoparticle (LNP)-formulated mRNA encoding human...
4.
Gruber C, Krautner L, Bergant V, Grass V, Ma Z, Rheinemann L, et al.
Cell Discov
. 2024 Apr;
10(1):42.
PMID: 38609360
No abstract available.
5.
Jakwerth C, Grass V, Erb A, Pichlmair A, Boonen G, Butterweck V, et al.
Biomed Pharmacother
. 2023 Dec;
170:115959.
PMID: 38061134
Background: The intensified search for low-threshold herbal anti-viral drugs would be of great advantage in prevention of early stages of infection. Since the SARS-CoV-2 Omicron variant has prevailed in western...
6.
Emslander Q, Krey K, Hamad S, Maidl S, Oubraham L, Hesse J, et al.
Viruses
. 2023 Aug;
15(8).
PMID: 37632105
Angiotensin-converting enzyme 2 (ACE2) is the central entry receptor for SARS-CoV-2. However, surprisingly little is known about the effects of host regulators on ACE2 localization, expression, and the associated influence...
7.
Grass V, Hardy E, Kobert K, Rastgou Talemi S, Decembre E, Guy C, et al.
Commun Biol
. 2022 Oct;
5(1):1115.
PMID: 36271143
Zika virus (ZIKV) infection can cause important developmental and neurological defects in Humans. Type I/III interferon responses control ZIKV infection and pathological processes, yet the virus has evolved various mechanisms...
8.
Mateyka L, Grass V, Pichlmair A, Busch D, DIppolito E
STAR Protoc
. 2022 Sep;
3(4):101699.
PMID: 36152303
The quality of an antigen-specific CD8 T cell repertoire is crucial for the clearance of intracellular pathogens, in particular for viral infections. Here, we describe killing assays to determine the...
9.
Bergant V, Yamada S, Grass V, Tsukamoto Y, Lavacca T, Krey K, et al.
EMBO J
. 2022 Jul;
41(17):e111608.
PMID: 35833542
The SARS-CoV-2 infection cycle is a multistage process that relies on functional interactions between the host and the pathogen. Here, we repurposed antiviral drugs against both viral and host enzymes...
10.
Jocher G, Grass V, Tschirner S, Riepler L, Breimann S, Kaya T, et al.
EMBO Rep
. 2022 May;
23(6):e54305.
PMID: 35527514
The severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) is the causative agent of COVID-19, but host cell factors contributing to COVID-19 pathogenesis remain only partly understood. We identify the host metalloprotease ADAM17 as a facilitator...